GMP Compliant Solutions for Barrier Technologies and
Protecting Life with Technology - in order to live up to our guiding principle, a high degree of responsibility and know-how is required. For the implementation in the interests of our customers, employees and ultimately the patients, our values, quality, flexibility and healthy growth accompany us every day.
1982
Founded by Franz Ziel
1989: Construction of the first owned company building (Plant 1)
1996: Olaf Ziel joins the company
2002: 1st expansion of Plant 1
2003: Construction of the first containment isolators
Ing. Franz Ziel, Founder
2004
Construction of the first aseptic isolators
2009: 2nd expansion of Plant 1 & Franz Ziel leaves the company
2010: Development of our own W-LAN glove testing system (GTS)
2011: Construction of the first aseptic / toxic isolator lines
2012: Construction of the second company building (Plant 2)
2013: Establishment of our own microbiology laboratory
2015: Market launch FZ-BDS – Integrated Bio-Decon System with vH2O2
2018: Construction of the third company building (Plant 3)
2020: Planning of Plant 4
2021: Construction of Plant 4
Today: 210 employees
2022
40th Anniversary
Quality Policy
Current Good manufacturing practice (cGMP) requires an understanding of process and associated science to manage contamination risks in sterile medicinal products and Advanced Therapeutic Medicinal (ATMPs) product manufacturing.
At Franz Ziel we provide support in the process and science of Environmental control, Cross contamination Control and Aseptic-Containment via development of integrated process solutions based on Barrier technologies; Isolators/ RABS and associated decontamination processes.
Aseptic Containment, the combination of highest levels of contamination control, cross contamination control and operator protection is a challenge we meet.